Daily aspirin lowers the risk of cancer in obese patients

Aspirin cut cancer risk

A DAILY dose of aspirin can dramatically reduce the risk of cancer for people who are overweight, a new study claims.

 

UK scientists found that being overweight can more than double the risk of developing colon cancer.

But the 10-year study found the risk could be counteracted by regularly taking the “wonder” pill.

It is the latest research to claim aspirin can be a powerful weapon in the battle against cancer.

This adds to the growing evidence linking an increased inflammatory process, which obesity increases, to an increased risk of cancer

Professor Sir John Burn, Newcastle University

 

The international study, published in the Journal of Clinical Oncology, covered 43 centres in 16 countries and followed nearly 1,000 patients with a family history of an inherited genetic disorder called Lynch Syndrome.

Around half of people with the disease go on to develop cancer.

Newcastle University’s Professor Sir John Burn, who led the research team, said: “This adds to the growing evidence linking an increased inflammatory process, which obesity increases, to an increased risk of cancer.

One explanation is that the aspirin may be suppressing that inflammation, which opens up new avenues of research into the cause of cancer.”